Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
AbstractMelatonin is an indolic hormone that regulates a plethora of functions ranging from the regulation of circadian rhythms and antioxidant properties to the induction and maintenance of tumor suppressor pathways. It binds to specific receptors as well as to some cytosolic proteins, leading to several cellular signaling cascades. Recently, the involvement of melatonin in cancer insurgence and progression has clearly been demonstrated. In this review, we will first describe the structure and functions of melatonin and its receptors, and then discuss both molecular and epidemiological evidence on melatonin anticancer effects. Finally, we will shed light on potential cross-talk between melatonin signaling and the Hippo signaling pathway, along with the possible implications for cancer therapy. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Sardo, F.L.; Muti, P.; Blandino, G.; Strano, S. Melatonin and Hippo Pathway: Is There Existing Cross-Talk? Int. J. Mol. Sci. 2017, 18, 1913.
Sardo FL, Muti P, Blandino G, Strano S. Melatonin and Hippo Pathway: Is There Existing Cross-Talk? International Journal of Molecular Sciences. 2017; 18(9):1913.Chicago/Turabian Style
Sardo, Federica Lo; Muti, Paola; Blandino, Giovanni; Strano, Sabrina. 2017. "Melatonin and Hippo Pathway: Is There Existing Cross-Talk?" Int. J. Mol. Sci. 18, no. 9: 1913.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.